David Trexler Email & Phone Number

Cambridge, Massachusetts, Us

Plan, direct and execute all commercial objectives (both business and corporate development) that drive corporate growth in the U.S.

Planegg, Bayern, De

Created a world-class oncology commercial unit and ensured enterprise excellence across commercial, sales, marketing, market access, business analytics and shared services.- Built the US subsidiary venture, including site location, talent, operational controls and leadership to enable MorphoSys AG to penetrate the US marketplace and commercialize its first asset.- Tapped an extensive oncology network to source talent and achieve commercial readiness ahead of the Prescription Drug User Fee Act for first Biological License Application approval within 17 months of hire.- Exceeded the 2020 launch year revenue by utilizing customer segmentation and new digital platforms borne out of the global pandemic.- Delivered in-line OPEX and EBIT by optimizing multi-million dollar programs, FTE, and G&A budget to maximize the impact of virtual programs.- Ran P&L with a deep understanding of the oncology market, including academic and community sites of care, Medicare Part B for infused drugs, pricing and the “buy and bill” model in US practice.- Capitalized on external relationships, including key opinion leaders, investors, and partners to ensure accurate data dissemination and scientific exchange for long-term data follow-up, which further cemented the dossier supporting the National Comprehensive Cancer network (NCCN) guideline inclusion.

Boston, Massachusetts, Us

Established Merck KGaA’s first commercial oncology footprint in the US.- Built the sales and marketing organization in preparation for its first Medicare Part B infused product launch in the emerging immune-oncology space.- Introduced the PLAIR import program to expedite product availability in the US post FDA approval.- Launched Bavencio (avelumab) for mMCC and exceeded market share goals in year one.- Prepared the organization for an additional indication in RCC.- Co-chaired the US Joint Steering Committee with Pfizer our co-commercialization partner.

Nutley, Nj, Us

Led the oncology portfolio and was instrumental in opening new markets in Brazil, Mexico and Canada.- Launched Halaven for metastatic breast cancer and was the first agent to show overall survival in late line therapy.- Exceeded launch year expectations with a significant increase in net sales. - Drove market share growth across solid tumor, hematologic, and supportive care oncology brands, including Aloxi, Dacogen, Halaven, ONTAK, Targretin, Fragmin, and Gliadel.- Spearheaded commercial readiness for Lenvima, an oral TKI for thyroid cancer and surpassed revenue expectations in the first year.

Nutley, Nj, Us

Headed Commercial Sales and Marketing team, and held the role of Executive member of the Americas Operating Committee.

Nutley, Nj, Us

Led Marketing and Business Operations team. - Formed a co-commercialization relationship with multiple companies, including Pfizer, J&J, PriCara, Helsinn, SuperGen, MGI, Ligand and Arena Pharmaceuticals.

Nutley, Nj, Us

Nutley, Nj, Us

Nutley, Nj, Us

Canonsburg, Pennsylvania, Us

Paris, France, Fr

Promoted through a series of 11 progressive sales and product management roles over an 18 year period.

Executive Mba

Bachelor Of Science - Bs, Biology (Honors)